Azithronycine in management of brucellosis A clinical trial
Tanta Medical Journal. 1997; 25 (Supp. 1): 243-52
em Inglês
| IMEMR
| ID: emr-47087
ABSTRACT
64 cases clinically and serologically proved brucellosis [Br] in adult and pediatric age. 40 male and 24 female were given 2 courses each of six days 500 mg Azithromycine [Az] in a single morning dose one hour before breakfast with 5 days rest in between, children were given 8-10 mg/Kg body Wt. They were hospitalized maximally for 6 days and followed for six month. All cases were cured with no relapses [100% cure rate] with very minimal side effects. It is also cost effective
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Brucelose
/
Incidência
/
Azitromicina
/
Gerenciamento Clínico
Tipo de estudo:
Estudo de incidência
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Tanta Med. J.
Ano de publicação:
1997
Similares
MEDLINE
...
LILACS
LIS